News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
455,322 Results
Type
Article (21466)
Company Profile (108)
Press Release (433733)
Multimedia
Podcasts (53)
Webinars (13)
Section
Business (123790)
Career Advice (1342)
Deals (22435)
Drug Delivery (63)
Drug Development (56531)
Employer Resources (86)
FDA (12294)
Job Trends (9654)
News (217730)
Policy (21231)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1842)
Accelerated approval (34)
Adcomms (29)
Allergies (110)
Alliances (34936)
ALS (157)
Alzheimer's disease (1361)
Antibody-drug conjugate (ADC) (322)
Approvals (12504)
Artificial intelligence (511)
Autoimmune disease (133)
Automation (36)
Bankruptcy (163)
Best Places to Work (8553)
BIOSECURE Act (8)
Biosimilars (129)
Biotechnology (86)
Bladder cancer (139)
Brain cancer (55)
Breast cancer (603)
Cancer (4502)
Cardiovascular disease (317)
Career advice (1112)
Career pathing (20)
CAR-T (246)
CDC (18)
Cell therapy (705)
Cervical cancer (34)
Clinical research (49567)
Collaboration (1676)
Company closure (3)
Compensation (919)
Complete response letters (66)
COVID-19 (1660)
CRISPR (86)
C-suite (772)
Cystic fibrosis (130)
Data (5366)
Decentralized trials (2)
Denatured (10)
Depression (108)
Diabetes (374)
Diagnostics (5155)
Digital health (37)
Diversity (6)
Diversity, equity & inclusion (26)
Drug discovery (239)
Drug pricing (68)
Drug shortages (10)
Duchenne muscular dystrophy (186)
Earnings (50440)
Editorial (20)
Employer branding (9)
Employer resources (73)
Events (64809)
Executive appointments (879)
FDA (15129)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (21)
Funding (1428)
Gene editing (181)
Generative AI (46)
Gene therapy (523)
GLP-1 (582)
Government (2642)
Grass and pollen (5)
Guidances (351)
Healthcare (12824)
HIV (49)
Huntington's disease (39)
IgA nephropathy (72)
Immunology and inflammation (193)
Immuno-oncology (51)
Indications (91)
Infectious disease (1868)
Inflammatory bowel disease (176)
Inflation Reduction Act (6)
Influenza (95)
Intellectual property (230)
Interviews (264)
IPO (11300)
IRA (16)
Job creations (1474)
Job search strategy (890)
JPM (42)
Kidney cancer (16)
Labor market (46)
Layoffs (307)
Leadership (19)
Legal (3087)
Liver cancer (85)
Longevity (12)
Lung cancer (625)
Lymphoma (325)
Machine learning (40)
Management (26)
Manufacturing (671)
MASH (147)
Medical device (9835)
Medtech (9883)
Mergers & acquisitions (12148)
Metabolic disorders (886)
Multiple sclerosis (119)
NASH (15)
Neurodegenerative disease (277)
Neuropsychiatric disorders (72)
Neuroscience (2420)
Neurotech (1)
NextGen: Class of 2026 (4007)
Non-profit (3039)
Now hiring (16)
Obesity (362)
Opinion (189)
Ovarian cancer (156)
Pain (170)
Pancreatic cancer (211)
Parkinson's disease (251)
Partnered (34)
Patents (439)
Patient recruitment (431)
Peanut (45)
People (37496)
Pharmaceutical (19)
Pharmacy benefit managers (9)
Phase 1 (16206)
Phase 2 (21506)
Phase 3 (17019)
Pipeline (4643)
Policy (136)
Postmarket research (1097)
Preclinical (6235)
Press Release (61)
Prostate cancer (222)
Psychedelics (36)
Radiopharmaceuticals (263)
Rare diseases (767)
Real estate (3079)
Recruiting (32)
Regulatory (19259)
Reports (38)
Research institute (1779)
Resumes & cover letters (278)
Rett syndrome (27)
RNA editing (18)
RSV (50)
Schizophrenia (120)
Series A (241)
Series B (187)
Service/supplier (7)
Sickle cell disease (81)
Special edition (17)
Spinal muscular atrophy (119)
Sponsored (30)
Startups (2504)
State (2)
Stomach cancer (18)
Supply chain (72)
Tariffs (31)
The Weekly (43)
Vaccines (644)
Venture capital (59)
Weight loss (184)
Women's health (60)
Worklife (7)
Date
Last 7 days (487)
Last 30 days (1706)
Last 365 days (25461)
2026 (2453)
2025 (25768)
2024 (28517)
2023 (32113)
2022 (41043)
2021 (42996)
2020 (39323)
2019 (31549)
2018 (23138)
2017 (22460)
2016 (19753)
2015 (22646)
2014 (16063)
2013 (13020)
2012 (14069)
2011 (14340)
2010 (12632)
Location
Africa (425)
Alabama (81)
Alaska (5)
Arizona (153)
Arkansas (12)
Asia (27566)
Australia (4524)
California (9123)
Canada (2873)
China (1000)
Colorado (374)
Connecticut (430)
Delaware (271)
Europe (60701)
Florida (1388)
Georgia (294)
Hawaii (3)
Idaho (41)
Illinois (640)
India (50)
Indiana (433)
Iowa (20)
Japan (387)
Kansas (107)
Kentucky (26)
Louisiana (18)
Maine (65)
Maryland (1075)
Massachusetts (6792)
Michigan (276)
Minnesota (398)
Mississippi (4)
Missouri (102)
Montana (27)
Nebraska (19)
Nevada (97)
New Hampshire (71)
New Jersey (2386)
New Mexico (28)
New York (2493)
North Carolina (1269)
North Dakota (10)
Northern California (4486)
Ohio (266)
Oklahoma (17)
Oregon (23)
Pennsylvania (1882)
Puerto Rico (16)
Rhode Island (38)
South America (605)
South Carolina (63)
South Dakota (1)
Southern California (3562)
Tennessee (140)
Texas (1449)
United States (32687)
Utah (292)
Vermont (1)
Virginia (218)
Washington D.C. (48)
Washington State (729)
West Virginia (3)
Wisconsin (105)
Wyoming (2)
455,322 Results for "advanced accelerator applications".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Endomimetics Announces Strategic Restructuring into IP Foundry to Accelerate Bionanomatrix(TM) Clinical Applications
February 5, 2026
·
3 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Insights
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like MPS II moving into the spotlight.
February 4, 2026
·
3 min read
·
Jennifer Smith-Parker
Press Releases
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
January 28, 2026
·
4 min read
Press Releases
Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection
January 13, 2026
·
4 min read
Press Releases
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
January 13, 2026
·
7 min read
Press Releases
Kincell Bio Advances Key Leaders to Accelerate Innovations for Reliable, High Quality Patient Supply in Cell Therapy Manufacturing
January 13, 2026
·
4 min read
Press Releases
Atossa Therapeutics Details Accelerated FDA Strategy to Advance (Z)-Endoxifen Across Breast Cancer Continuum
December 4, 2025
·
6 min read
Press Releases
BenchSci and Mila Partner to Advance AI for Biological Inference and Accelerate Drug Discovery
November 13, 2025
·
3 min read
Press Releases
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease
January 29, 2026
·
5 min read
1 of 45,533
Next
